Inhibition of Peptide Aggregation and Neurotoxicity by Citrate |
Park, Yong-Hoon
(Inam Neuroscience Research Center College of Medicine, Wonkwang University)
Kim, Young-Jin (Department of Neurology, Sanbon Medical Center, College of Medicine, Wonkwang University) Son, Il-Hong (Inam Neuroscience Research Center College of Medicine, Wonkwang University) Yang, Hyun-Duk (Inam Neuroscience Research Center College of Medicine, Wonkwang University) |
1 | Barrow CJ, Zagorski MG. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. Science 253: 179−182, 1991 DOI PUBMED ScienceOn |
2 | Brus L. Noble metal nanocrystals: plasmon electron transfer photochemistry and single-molecule raman spectroscopy. Acc Chem Res 41: 1742−1749, 2008 DOI PUBMED ScienceOn |
3 | Cao M, Han Y, Wang J, Wang Y. Modulation of fibrillogenesis of amyloid (1-40) peptide with cationic gemini surfactant. J Phys Chem B 111: 13436−13443, 2007 DOI PUBMED ScienceOn |
4 | Citron M. Strategies for disease modification in Alzheimer's disease. Nat Rev Neurosci 5: 677−685, 2004 DOI PUBMED ScienceOn |
5 | Hensley K, Carney JM, Mattson MP, Aksenova MV, Harris ME, Wu JF, Floyd RA, Butterfield DA. A model for -amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci USA 91: 3270−3274, 1994 DOI ScienceOn |
6 | Ji SR, Wu Y, Sui SF. Study of beta-amyloid peptide (Abeta40) insertion into phospholipid membranes using monolayer technique. Biochemistry (Mosc) 67: 1283−1288, 2002 DOI PUBMED ScienceOn |
7 | Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Dobeli H, Schubert D, Riek R. 3D structure of Alzheimer's amyloid- (1-42) fibrils. Proc Natl Acad Sci USA 102: 17342−17347, 2005 DOI ScienceOn |
8 | McConnell S, Riggs J. Alzheimer's research: can it help save our nation's entitlement programs? Alzheimer Dementia 1: 84−86, 2005 DOI ScienceOn |
9 | Pallitto MM, Ghanta J, Heinzelman P, Kiessling LL, Murphy RM. Recognition sequence design for peptidyl modulators of beta- amyloid aggregation and toxicity. Biochemistry 38: 3570−3578, 1999 DOI PUBMED ScienceOn |
10 | Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. Aggregation related toxicity of synthetic beta-amyloid protein in hippocampal cultures, Eur J Pharmacol 207: 367−368, 1991 DOI PUBMED ScienceOn |
11 | Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 64: 253−265, 1995 DOI PUBMED ScienceOn |
12 | Puntel RL, Roos DH, Grotto D, Garcia SC, Nogueira CW, Rocha JB. Antioxidant properties of Krebs cycle intermediates against malonate pro-oxidant activity in vitro: a comparative study using the colorimetric method and HPLC analysis to determine malondialdehyde in rat brain homogenates. Life Sci 81: 51−62, 2007 DOI PUBMED ScienceOn |
13 | Sabate R, Gallardo M, Estelrich J. An autocatalytic reaction as a model for the kinetics of the aggregation of beta-amyloid. Biopolymers 71: 190−195, 2003 DOI PUBMED ScienceOn |
14 | Watanabe K, Segawa T, Nakamura K, Kodaka M, Konakahara T, Okuno H. Identification of the molecular-interaction site of amyloid beta peptide by using a fluorescence assay. J Pept Res 58: 342−346, 2001 DOI ScienceOn |
15 | Wood SJ, MacKenzie L, Maleeff B, Hurle MR, Wetzel R. Selective inhibition of Abeta fibril formation. J Biol Chem 271: 4086−4092, 1996a DOI PUBMED |
16 | Yang HD, Son IH, Lee SS, Park YH. Protective effect of citrate against A-induced neurotoxicity in PC12 cells. Mol Cell Toxicol 4: 157−163, 2008 |
17 | Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741−766, 2001 PUBMED ScienceOn |
18 | Bokvist M, Lindstrom F, Watts A, Grobner G. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J Mol Biol 335: 1039−1049, 2004 DOI PUBMED ScienceOn |
19 | Seiffert D, Bradley JD, Rominger CM, Rominger DH, Yang F, Meredith JE Jr, Wang Q, Roach AH, Thompson LA, Spitz SM, Higaki JN, Prakash SR, Combs AP, Copeland RA, Arneric SP, Hartig PR, Robertson DW, Cordell B, Stern AM, Olson RE, Zaczek R. Presenilin-1 and -2 are molecular targets for gamma- secretase inhibitors. J Biol Chem 275: 34086−34091, 2000 DOI PUBMED ScienceOn |
20 | Sisodia SS, St George-Hyslop PH. Gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat Rev Neurosci 3: 281−290, 2002 DOI PUBMED ScienceOn |
21 | Jeng US, Lin TL, Lin JM, Ho DL. Contrast variation SANS for the solution structure of the -amyloid peptide1-40 influenced by SDS surfactants. Physica B 385−386: 865−867, 2006 DOI ScienceOn |
22 | Snyder SW, Ladror US, Wade WS, Wang GT, Barrett LW, Matayoshi ED, Huffaker HJ, Krafft GA, Holzman TF. Amyloid- beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J 67: 1216−1228, 1994 DOI PUBMED ScienceOn |
23 | Howlett DR, Jennings KH, Lee DC, Clark MS, Brown F, Wetzel R, Wood SJ, Camilleri P, Roberts GW. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4: 23−32, 1995 DOI PUBMED ScienceOn |
24 | Soreghan B, Kosmoski J, Glabe C. Surfactant properties of Alzheimer's Abeta peptides and the mechanism of amyloid aggregation. J Biol Chem 269: 28551−28554, 1994 PUBMED ScienceOn |
25 | Bush AI, Pettingell WH, Multhaup G, d Paradis M, Vonsattel JP, Gusella JF, Beyreuther K, Masters CL, Tanzi RE. Rapid induction of Alzheimer Abeta amyloid formation by zinc. Science 265: 1464−1467, 1994 DOI PUBMED ScienceOn |
26 | Gschwind M, Huber G. Apoptotic cell death induced by beta-amyloid 1-42 peptide is cell type dependent. J Neurochem 65: 292−300, 1995 DOI PUBMED ScienceOn |
27 | Wang SS, Chen YT, Chou SW. Inhibition of amyloid fibril formation of beta-amyloid peptides via the amphiphilic surfactants. Biochim Biophys Acta 1741: 307−313, 2005 DOI PUBMED |
28 | Sabate R, Estelrich J. Stimulatory and inhibitory effects of alkyl bromide surfactants on beta-amyloid fibrillogenesis. Langmuir 21: 6944−6949, 2005b DOI PUBMED ScienceOn |
29 | Seilheimer B, Bohrmann B, Bondolfi L, Mller F, Stuber D, Dobeli H. The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology. J Struct Biol 119: 59−71, 1997 DOI PUBMED ScienceOn |
30 | Koh JY, Yang LLY, Cotman CW. Beta-amyloid protein increases vulnerability of cultured neurons to excitotoxins. Brain Res 533: 315−320, 1990 DOI PUBMED ScienceOn |
31 | Wood SJ, Maleeff B, Hart T, Wetzel R. Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta. J Mol Biol 256: 870−877, 1996b DOI PUBMED ScienceOn |
32 | Nowick JS, Lam KS, Khasanova TV, Kemnitzer WE, Maitra S, Mee HT, Liu R. An unnatural amino acid that induces beta-sheet folding and interaction in peptides. J Am Chem Soc 124: 4972−4973, 2002 DOI PUBMED ScienceOn |
33 | Sabate R, Estelrich J. Evidence of the existence of micelles in the fibrillogenesis of beta-amyloid peptide. J Phys Chem B 109: 11027−11032, 2005a DOI PUBMED ScienceOn |
34 | Halverson K, Fraser PE, Kirschner DA, Lansbury PT Jr. Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments. Biochemistry 29: 2639−2644, 1990 DOI PUBMED ScienceOn |
35 | Lowe TL, Strzelec A, Kiessling LL, Murphy RM. Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF. Biochemistry 40: 7882−7889, 2001 DOI PUBMED ScienceOn |
36 | Pappolla M, Bozner P, Soto C, Shao H, Robakis NK, Zagorski M, Frangione B, Ghiso J. Inhibition of Alzheimer beta-fibrillogenesis by melatonin. J Biol Chem 273: 7185−7188, 1998 DOI PUBMED ScienceOn |
37 | Cummings JL, Doody R, Clark C. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology 69: 1622−1634, 2007 DOI PUBMED ScienceOn |
38 | Scarpini E, Scheltens P, Feldman H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol 2: 539−547, 2003 DOI ScienceOn |
39 | Rangachari V, Reed DK, Moore BD, Rosenberry TL. Secondary structure and interfacial aggregation of amyloid-beta (1-40) on sodium dodecyl sulfate micelles. Biochemistry 45: 8639−8648, 2006 DOI PUBMED ScienceOn |
40 | Marcinowski KJ, Shao H, Clancy EL, Zagorski MG. Solution structure model of residues 1-28 of the amyloid beta peptide when bound to micelles. J Am Chem Soc 120: 11082−11091, 1998 DOI ScienceOn |
41 | Pereira C, Agostinho P, Moreira PI, Cardoso SM, Oliveira CR. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies. Curr Drug Targets CNS Neurol Disord 4: 383−403, 2005 DOI ScienceOn |
42 | Jarrett JT, Berger EP, Lansbury Jr. PT. The carboxy terminus of the -amyloid protein is critical for the seeding of amyloid formation: implication for the pathogenesis of Alzheimer's disease. Biochemistry 32: 4693−4697, 1993 DOI PUBMED ScienceOn |
43 | Khandogin J, Brooks III CL. Linking folding with aggregation in Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci USA 104: 16880−16885, 2007 DOI ScienceOn |
44 | Lazo ND, Grant MA, Condron MC, Rigby AC, Teplow DB. On the nucleation of amyloid beta-protein monomer folding. Protein Sci 14: 1581−1596, 2005 DOI ScienceOn |
45 | Lorenzo A, Yankner BA. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci USA 91: 12243−12247, 1994 DOI ScienceOn |
46 | Mook-Jung I, Joo I, Sohn S, Kwon HJ, Huh K, Jung MW. Estrogen blocks neurotoxic effects of beta-amyloid (1-42) and induces neurite extension in B103 cells. Neurosci Lett 235: 101−104, 1997 DOI PUBMED ScienceOn |
47 | Rochet JC Jr, Lansbury PT. Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 10: 60−68, 2000 DOI PUBMED ScienceOn |
48 | Salomon AR, Marcinowski KJ, Friedland RW, Zagorski MG. Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry 35: 13568−13578, 1996. DOI PUBMED ScienceOn |
49 | Yankner BA. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16: 921−932, 1996 DOI PUBMED ScienceOn |
50 | Kisilevsky R, Lemieux LJ, Fraser PE, Kong X, Hultin PG, Szarek WA. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat Med 1: 143−148, 1995 DOI PUBMED ScienceOn |
51 | Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB. On the nucleation and growth of amyloid beta-protein fibrils: Detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci USA 93: 1125−1129, 1996 DOI ScienceOn |
52 | Pike CJ, burdick D, Walencewicz AJ, Glabe CG, Cotman CW. Neurodegeneration induced by -amyloid peptides in vitro: the role of peptide assembly state. J Neruosci 13: 1676−1687, 1993 ScienceOn |
53 | Lizard G, Fournel S, Genestier L, Dhedin N, Chaput C, Flacher M, Mutin M, Panaye G, Revillard JP. Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. Cytometry 21: 275−283, 1995 DOI PUBMED ScienceOn |
54 | Ban T, Hoshino M, Takahashi S, Hamada D, Hasegawa K, Naiki H, Goto Y. Direct observation of Abeta amyloid fibril growth and inhibition. J Mol Biol 344: 757−767, 2004 DOI PUBMED ScienceOn |